Regeneron Pharmaceuticals, Inc.
ANTI-TMPRSS2 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS
Last updated:
Abstract:
The present disclosure provides antibodies and antigen-binding fragments thereof that bind specifically to TMPRSS2 and methods of using such antibodies and fragments for treating or preventing viral infections (e.g., coronavirus infections or influenza virus infections).
Status:
Application
Type:
Utility
Filling date:
9 Feb 2021
Issue date:
12 Aug 2021